Small scale manufacturing for early clinical trials
The first doses of the Oxford-AstraZeneca COVID-19 vaccine were produced at the Clinical BioManufacturing Facility.
These first doses enabled trials to begin in April 2020. You can read the full details of the efforts to manufacture this first batch on the CBF website